Abstract:Background: Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and devastating cancers without effective treatments. Amplified in breast cancer 1 (AIB1) is a member of the steroid receptor coactivator family that mediates the transcriptional activities of nuclear receptors. While AIB1 is associated with the initiation and progression of multiple cancers, the mechanism by which AIB1 contributes to PDAC progression remains unknown. In this study, we aimed to explore the role of AIB1 in the progression of PDAC and elucidate the underlying mechanisms.Methods: The clinical significance and mRNA level of AIB1 in PDAC were studied by database analysis. To demonstrate whether AIB1 mediates the malignant features of PDAC cells, namely, proliferation, migration, invasion, we performed real-time PCR and Western blot analysis, established xenograft models and used in vivo metastasis assay. With insights into the mechanism of AIB1, we performed RNA sequencing (Seq), ChIP-Seq, luciferase reporter assays and pull-down assays. Furthermore, we analyzed the relationship between AIB1 expression and its target expression in PDAC cells and patients and explored whether PDAC cells with high AIB1 levels are sensitive to inhibitors of its target.Results: We found that AIB1 was significantly upregulated in PDAC and associated with its malignancy. Silencing AIB1 impaired hedgehog (Hh) activation by reducing the expression of smoothened (SMO), leading to cell cycle arrest and the inhibition of PDAC cell proliferation. In addition, AIB1, via upregulation of integrin αv (ITGAV) expression, promoted extracellular matrix (ECM) signaling, which played an important role in PDAC progression. Further studies showed that AIB1 preferably bound to AP-1 related elements and served as a coactivator for enhancing the transcriptional activity of MafB, which promoted the expression of SMO and ITGAV. PDAC cells with high AIB1 levels were sensitive to Hh signaling inhibitors, suggesting that blocking Hh activation is an effective treatment against PDAC with high AIB1 expression.Conclusions: These findings reveal that AIB1 is a crucial oncogenic regulator associated with PDAC progression via Hh and ECM signaling and suggest potential therapeutic targets for PDAC treatment.

Coordinated Regulation of Aib1 Transcriptional Activity by Sumoylation and Phosphorylation

Transcriptional Regulation of Pp2a-A Alpha is Mediated by Multiple Factors Including Ap-2 Alpha, Creb, Ets-1, and Sp-1

Differential Gene Regulation by the SRC Family of Coactivators.

AIP1 is Critical in Transducing IRE1-mediated Endoplasmic Reticulum Stress Response

An Autoregulatory Enhancer Controls Mammary-Specific Stat5 Functions

AIB1 Enhances Estrogen-Dependent Induction of Cyclin D1 Expression.

Molecular Mechanism for the Potentiation of the Transcriptional Activity of Human Liver Receptor Homolog 1 by Steroid Receptor Coactivator-1

Essential Phosphatases and A Phospho-Degron Are Critical for Regulation of Src-3/Aib1 Coactivator Function and Turnover

SRC-3, a Steroid Receptor Coactivator: Implication in Cancer

Estrogen receptor co-activator (AIB1) protein expression by automated quantitative analysis (AQUA) in a breast cancer tissue microarray and association with patient outcome

Upregulation of amplified in breast cancer 1 contributes to pancreatic ductal adenocarcinoma progression and vulnerability to blockage of hedgehog activation

An AIB1 Isoform Alters Enhancer Access and Enables Progression of Early-Stage Triple-Negative Breast Cancer

Regulation of SRC family coactivators by post-translational modifications.

Amplified in breast cancer 1 promotes colorectal cancer progression through enhancing notch signaling

Brg-1 is Recruited to Estrogen-Responsive Promoters and Cooperates with Factors Involved in Histone Acetylation

Sumoylation of SAP130 regulates its interaction with FAF1 as well as its protein stability and transcriptional repressor function

Differential Regulation of Androgen Receptor by Pim-1 Kinases Via Phosphorylation-Dependent Recruitment of Distinct Ubiquitin E3 Ligases

SIP, a Novel Ankyrin Repeat Containing Protein, Sequesters Steroid Receptor Coactivators in the Cytoplasm

PIAS3 Induction of PRB Sumoylation Represses PRB Transactivation by Destabilizing Its Retention in the Nucleus

ABI1 regulates transcriptional activity of Androgen Receptor by novel DNA and AR binding mechanism

SUMO modification regulates the transcriptional activity of XBP1.